These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2902130)

  • 21. Anti-Pseudomonas aeruginosa activity of an intravenous human IgG preparation in burned mice.
    Collins MS; Roby RE
    J Trauma; 1983 Jun; 23(6):530-4. PubMed ID: 6408266
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Passive immunotherapy for treatment of endobronchitis in cystic fibrosis].
    Moss RB
    Infusionsther Transfusionsmed; 1993 Apr; 20 Suppl 1():42-6; discussion 47. PubMed ID: 8499750
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single versus combination antibiotic therapy for pneumonia due to Pseudomonas aeruginosa in neutropenic guinea pigs.
    Rusnak MG; Drake TA; Hackbarth CJ; Sande MA
    J Infect Dis; 1984 Jun; 149(6):980-5. PubMed ID: 6429255
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Experiences with a Pseudomonas immunoglobulin in artificially respirated patients with Pseudomonas pneumonia at a surgical intensive care unit].
    Böhm D
    Infection; 1987; 15(1):73-5. PubMed ID: 3106232
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of anti-OprF-OprI immunoglobulin on APACHE II score in a porcine two-hit model of hemorrhagic shock/resuscitation and pseudomonas aeruginosa sepsis.
    Haberstroh J; Gilleland HE; von Specht BU
    Eur Surg Res; 2005; 37(5):265-73. PubMed ID: 16374008
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Experimental pneumonia due to Pseudomonas aeruginosa in leukopenic dogs: prolongation of survival by combined treatment with passive antibody to Pseudomonas and granulocyte transfusions.
    Kazmierowski JA; Reynolds HY; Kauffman JC; Durbin WA; Graw RG; Devlin HB
    J Infect Dis; 1977 Mar; 135(3):438-46. PubMed ID: 403242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibiotic treatment of experimental Pseudomonas aeruginosa pneumonia in guinea pigs: comparison of aerosol and systemic administration.
    Makhoul IR; Merzbach D; Lichtig C; Berant M
    J Infect Dis; 1993 Nov; 168(5):1296-9. PubMed ID: 8228367
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pseudomonas immunoglobulin and vaccine in burn patients.
    Bose B
    Lancet; 1981 Feb; 1(8217):435. PubMed ID: 6110056
    [No Abstract]   [Full Text] [Related]  

  • 29. Efficacy of modified human immune serum globulin in the treatment of experimental murine infections with seven immunotypes of Pseudomonas aeruginosa.
    Davis SD
    J Infect Dis; 1975 Jun; 131(6):717-21. PubMed ID: 805814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protective activity of an intravenous immune globulin (human) enriched in antibody against lipopolysaccharide antigens of Pseudomonas aeruginosa.
    Collins MS; Roby RE
    Am J Med; 1984 Mar; 76(3A):168-74. PubMed ID: 6424446
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Production and characterization of a human hyperimmune intravenous immunoglobulin against Pseudomonas aeruginosa and Klebsiella species.
    Cryz SJ; Fürer E; Sadoff JC; Fredeking T; Que JU; Cross AS
    J Infect Dis; 1991 May; 163(5):1055-61. PubMed ID: 1902245
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A polyvalent human gamma-globulin immune to Pseudomonas aeruginosa: passive protection of mice against lethal infection.
    Fisher MW
    J Infect Dis; 1977 Aug; 136 Suppl():S181-5. PubMed ID: 70492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Protective effect of Pseudomonas-specific immunoglobulin from the rabbit and of active immunization in experimental Pseudomonas sepsis in mice].
    Trautmann M; Brückner O; Hahn H
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Jul; 252(3):370-83. PubMed ID: 6215803
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Use of hyperimmune anti-Pseudomonas plasma in the treatment of infectious complications].
    Grishina IA; Terekhova RP; Marchuk AI; Elagina LV; Ostrovskaia EV; Nezhlukto AIa
    Khirurgiia (Mosk); 1990 Nov; (11):121-3. PubMed ID: 2127294
    [No Abstract]   [Full Text] [Related]  

  • 35. [Use of pseudomonas immunoglobulin in ventilated patients at an interdisciplinary surgical intensive care station].
    Class I; Junginger W; Klöss T
    Infection; 1987; 15 Suppl 2():S67-70. PubMed ID: 3112024
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Use of Sanoserum P.A. in the treatment of Pseudomonas aeruginosa infection].
    Philips R; Philips I
    Klin Oczna; 1987 Apr; 89(4):158-9. PubMed ID: 3118093
    [No Abstract]   [Full Text] [Related]  

  • 37. Bivalent flagellin immunotherapy protects mice against Pseudomonas aeruginosa infections in both acute pneumonia and burn wound models.
    Ahmadi H; Behrouz B; Irajian G; Amirmozafari N; Naghavi S
    Biologicals; 2017 Mar; 46():29-37. PubMed ID: 28065582
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Use of pseudomonas immunoglobulin. Indications and results].
    Werdan K; Melnitzki S; Pilz G; Reuschel-Janetschek E
    Anasth Intensivther Notfallmed; 1989 Jun; 24(3):153-61. PubMed ID: 2504071
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-Pseudomonas aeruginosa IgY antibodies promote bacterial opsonization and augment the phagocytic activity of polymorphonuclear neutrophils.
    Thomsen K; Christophersen L; Jensen PØ; Bjarnsholt T; Moser C; Høiby N
    Hum Vaccin Immunother; 2016 Jul; 12(7):1690-9. PubMed ID: 26901841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Passive immunization against Pseudomonas aeruginosa recombinant PilA in a murine burn wound model.
    Mousavi M; Behrouz B; Irajian G; Mahdavi M; Korpi F; Motamedifar M
    Microb Pathog; 2016 Dec; 101():83-88. PubMed ID: 27836762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.